Regulation of Osteoblast Metabolism by Lrp5

Lrp5 对成骨细胞代谢的调节

基本信息

  • 批准号:
    10721607
  • 负责人:
  • 金额:
    $ 30.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-10-10 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

Abstract Since the identification of causative mutations in Lrp5 in osteoporosis-pseudoglioma and the high bone mass syndrome, the low-density lipoprotein receptor-related protein 5 (Lrp5) has been firmly linked with osteoblast function in humans and animal models. In the previous funding period, we demonstrated that Wnt/b-catenin signaling through Lrp5 regulates long-chain fatty acid utilization by the osteoblast. Thus, transgenic mice lacking Lrp5 specifically in the osteoblast exhibited an increase in adipose tissue mass and developed a dyslipidemia in addition to the expected low bone mass phenotype. Moreover, genetic ablation of Cpt2, an obligate enzyme in long chain fatty acid catabolism, in the osteoblast impairs bone acquisition and led to an increase in serum lipids. Together, these data suggest that bone is a site of significant fatty acid utilization and that the regulation of osteoblast metabolism by Lrp5 contributes to both bone accrual and whole body energy balance. In this renewal application we will use genetic mouse models to (1) determine the mechanism by which fatty acids are acquired by the osteoblast and (2) assess the metabolic substrate requirements that are necessary for Wnt-stimulated bone formation. We hypothesize that fatty acid uptake will require the actions of Slc27a1 and/or CD36 and that inhibition of fatty acid utilization will be sufficient to inhibit the Wnt-induced increase in bone formation associated with Sost deficiency or expression of a Lrp5 high bone mass allele. These studies will further our understanding of the metabolic requirements of bone formation, the contribution of bone to metabolism, and the mechanisms by which Wnt/b-catenin signaling govern skeletal homeostasis.
摘要

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Parathyroid Hormone Reprograms Osteoblast Metabolism.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ryan C Riddle其他文献

Ryan C Riddle的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ryan C Riddle', 18)}}的其他基金

Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
  • 批准号:
    10590611
  • 财政年份:
    2022
  • 资助金额:
    $ 30.91万
  • 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中的骨-脂肪相互作用
  • 批准号:
    10706006
  • 财政年份:
    2022
  • 资助金额:
    $ 30.91万
  • 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
  • 批准号:
    10368975
  • 财政年份:
    2021
  • 资助金额:
    $ 30.91万
  • 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
  • 批准号:
    10202896
  • 财政年份:
    2021
  • 资助金额:
    $ 30.91万
  • 项目类别:
Endocrine Actions of Sclerostin
硬化素的内分泌作用
  • 批准号:
    10527338
  • 财政年份:
    2017
  • 资助金额:
    $ 30.91万
  • 项目类别:
Endocrine Actions of Sclerostin
硬化素的内分泌作用
  • 批准号:
    9898240
  • 财政年份:
    2017
  • 资助金额:
    $ 30.91万
  • 项目类别:
Endocrine Actions of Sclerostin
硬化素的内分泌作用
  • 批准号:
    10364394
  • 财政年份:
    2017
  • 资助金额:
    $ 30.91万
  • 项目类别:
Regulation of Osteoblast Metabolism by Lrp5
Lrp5 对成骨细胞代谢的调节
  • 批准号:
    9902408
  • 财政年份:
    2013
  • 资助金额:
    $ 30.91万
  • 项目类别:
Regulation of Osteoblast Metabolism by Lrp5
Lrp5 对成骨细胞代谢的调节
  • 批准号:
    9049491
  • 财政年份:
    2013
  • 资助金额:
    $ 30.91万
  • 项目类别:
Regulation of Osteoblast Metabolism by Lrp5
Lrp5 对成骨细胞代谢的调节
  • 批准号:
    8845550
  • 财政年份:
    2013
  • 资助金额:
    $ 30.91万
  • 项目类别:

相似海外基金

Regulation of Osteoblast Metabolism by Lrp5
Lrp5 对成骨细胞代谢的调节
  • 批准号:
    9902408
  • 财政年份:
    2013
  • 资助金额:
    $ 30.91万
  • 项目类别:
Regulation of Osteoblast Metabolism by Lrp5
Lrp5 对成骨细胞代谢的调节
  • 批准号:
    9049491
  • 财政年份:
    2013
  • 资助金额:
    $ 30.91万
  • 项目类别:
Regulation of Osteoblast Metabolism by Lrp5
Lrp5 对成骨细胞代谢的调节
  • 批准号:
    8845550
  • 财政年份:
    2013
  • 资助金额:
    $ 30.91万
  • 项目类别:
Regulation of osteoblast metabolism by Lrp5
Lrp5 对成骨细胞代谢的调节
  • 批准号:
    8705511
  • 财政年份:
    2013
  • 资助金额:
    $ 30.91万
  • 项目类别:
Regulation of Osteoblast Metabolism by Lrp5
Lrp5 对成骨细胞代谢的调节
  • 批准号:
    10372036
  • 财政年份:
    2013
  • 资助金额:
    $ 30.91万
  • 项目类别:
Regulation of osteoblast metabolism by Lrp5
Lrp5 对成骨细胞代谢的调节
  • 批准号:
    8557470
  • 财政年份:
    2013
  • 资助金额:
    $ 30.91万
  • 项目类别:
Gravitational Regulation of Osteoblast Genomics and Metabolism
成骨细胞基因组和代谢的重力调节
  • 批准号:
    8729096
  • 财政年份:
    2011
  • 资助金额:
    $ 30.91万
  • 项目类别:
Gravitational Regulation of Osteoblast Genomics and Metabolism
成骨细胞基因组和代谢的重力调节
  • 批准号:
    8326052
  • 财政年份:
    2011
  • 资助金额:
    $ 30.91万
  • 项目类别:
Gravitational Regulation of Osteoblast Genomics and Metabolism
成骨细胞基因组和代谢的重力调节
  • 批准号:
    8906852
  • 财政年份:
    2011
  • 资助金额:
    $ 30.91万
  • 项目类别:
Gravitational Regulation of Osteoblast Genomics and Metabolism
成骨细胞基因组和代谢的重力调节
  • 批准号:
    8154099
  • 财政年份:
    2011
  • 资助金额:
    $ 30.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了